Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Medicine and Dentistry
Pediatrics
100%
Childhood Cancer
90%
Malignant Neoplasm
55%
Neoplasm
42%
Tumor
41%
Adolescence
41%
Diseases
34%
Chemotherapy
32%
Acute Lymphoblastic Leukemia
28%
Radiation Therapy
27%
Rhabdomyosarcoma
27%
Overall Survival
26%
Ganglioneuroblastoma
26%
Systematic Review
25%
Soft Tissue Sarcoma
22%
Wilms' Tumor
21%
Ganglioglioma
20%
Pediatrics Patient
18%
Genetics
18%
Cancer
18%
Pediatric Cancer
17%
Event Free Survival
15%
Kidney Tumour
15%
Clinical Trial
13%
Quality of Life
13%
Cancer Therapy
13%
Oncology
12%
Late Effect
12%
Acute Myeloid Leukemia
12%
Biological Marker
11%
Cohort Analysis
10%
Melanoma
10%
Cancer in Young Adults
10%
Recurrent Disease
10%
Magnetic Resonance Imaging
10%
Central Nervous System Tumor
10%
Prevalence
9%
Adverse Event
9%
Solid Malignant Neoplasm
9%
Minimal Residual Disease
8%
Germinoma
8%
Hematopoietic Stem Cell Transplantation
8%
Osteosarcoma
8%
Organoid
8%
Hazard Ratio
7%
Risk Stratification
7%
Leukemia
7%
Metastatic Carcinoma
7%
Survival Rate
7%
Intracranial Tumor
7%
Medulloblastoma
7%
Targeted Therapy
7%
Pediatric Acute Myeloid Leukemia
7%
Germ Cell
6%
Immunotherapy
6%
Meta-Analysis
6%
Median Follow Up
6%
Prognostic Factor
6%
Precursor
6%
Differentiated Thyroid Cancer
5%
Progression Free Survival
5%
Hematopoietic Cell
5%
High Risk Population
5%
Central Nervous System
5%
Cancer Treatment
5%
T Cell
5%
B Cell
5%
Breast Cancer
5%
Randomized Controlled Trial
5%
Histology
5%
Arm
5%
Keyphrases
Tumor
25%
Acute Lymphoblastic Leukemia
24%
Pediatric
22%
Dutch
22%
Childhood Cancer
20%
Neuroblastoma
17%
Overall Survival
16%
Survivors
15%
Pediatric Patients
15%
Chemotherapy
15%
Rhabdomyosarcoma
14%
Children with Cancer
14%
Pediatric Oncology
14%
Wilms Tumor
13%
95% Confidence Interval
13%
Radiotherapy
13%
Event-free Survival
12%
High Risk
12%
Netherlands
12%
Risk Factors
11%
Organoids
11%
Pediatric Soft Tissue Sarcoma
10%
Acute Myeloid Leukemia
10%
Older Adults
10%
Late Effects
9%
Leukemia
8%
Pharmacokinetics
8%
Pediatric Cancer Patients
8%
Cancer Treatment
8%
Pediatric Acute Lymphoblastic Leukemia
7%
Health-related Quality of Life
7%
Childhood Acute Lymphoblastic Leukemia
7%
Working Diagnosis
7%
Meta-analysis
7%
Clinical Trials
7%
Pediatric Leukemia
7%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
7%
Medulloblastoma
6%
Hazard Ratio
6%
Renal Tumor
6%
Oncology
6%
Therapeutic Drug Monitoring
6%
In Cancer
5%
T Cells
5%
Europe
5%
Pediatric Cancer
5%
Pediatric Brain Tumor
5%
Clinical Outcomes
5%
Minimal Residual Disease
5%
After childhood
5%
Pediatric Tumors
5%
Targeted Therapy
5%
Central Nervous System Tumors
5%
Tumor Subtype
5%
BCP-ALL
5%
Randomized Controlled Trial
5%
Methotrexate
5%
Soft Tissue Sarcoma
5%
Hematopoietic Stem Cell Transplantation
5%